MTOR and colorectal carcinoma: The underlying mechanism of Polymet involved reprograming the immunosuppressive TME via adenosine 5′-monophosphate activated protein kinase (AMPK) pathway and mammalian target of rapamycin (mTOR) pathway, as well as lifting the abundance of anti-tumoral Lactobacillus in CRC tissues.